165 related articles for article (PubMed ID: 15288478)
1. Molecular-based prediction of early recurrence in hepatocellular carcinoma.
Kurokawa Y; Matoba R; Takemasa I; Nagano H; Dono K; Nakamori S; Umeshita K; Sakon M; Ueno N; Oba S; Ishii S; Kato K; Monden M
J Hepatol; 2004 Aug; 41(2):284-91. PubMed ID: 15288478
[TBL] [Abstract][Full Text] [Related]
2. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
[TBL] [Abstract][Full Text] [Related]
3. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; Nakamori S; Dono K; Umeshita K; Ueno N; Ishii S; Kato K; Monden M
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6029-38. PubMed ID: 15447987
[TBL] [Abstract][Full Text] [Related]
4. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
6. A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy.
Somura H; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Tsunedomi R; Yamada-Okabe H; Sawamura M; Eramoto M; Miyamoto T; Hamamoto Y; Oka M
Oncol Rep; 2008 Feb; 19(2):489-95. PubMed ID: 18202799
[TBL] [Abstract][Full Text] [Related]
7. Different molecular pathways determining extrahepatic and intrahepatic recurrences of hepatocellular carcinoma.
Iizuka N; Tamesa T; Sakamoto K; Miyamoto T; Hamamoto Y; Oka M
Oncol Rep; 2006 Nov; 16(5):1137-42. PubMed ID: 17016605
[TBL] [Abstract][Full Text] [Related]
8. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma.
Cheung ST; Leung KL; Ip YC; Chen X; Fong DY; Ng IO; Fan ST; So S
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):551-6. PubMed ID: 15701840
[TBL] [Abstract][Full Text] [Related]
9. A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approach.
Ho MC; Lin JJ; Chen CN; Chen CC; Lee H; Yang CY; Ni YH; Chang KJ; Hsu HC; Hsieh FJ; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1474-84. PubMed ID: 17009164
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
11. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Jeng KS; Sheen IS; Tsai YC
Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
[TBL] [Abstract][Full Text] [Related]
12. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
[TBL] [Abstract][Full Text] [Related]
13. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
[TBL] [Abstract][Full Text] [Related]
14. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation.
Wu L; Xu X; Shen J; Xie H; Yu S; Liang T; Wang W; Shen Y; Zhang M; Zheng S
J Surg Oncol; 2007 Jul; 96(1):62-8. PubMed ID: 17443726
[TBL] [Abstract][Full Text] [Related]
15. Resampling based on geographic patterns of hepatitis virus infection reveals a common gene signature for early intrahepatic recurrence of hepatocellular carcinoma.
Uchimura S; Iizuka N; Tamesa T; Miyamoto T; Hamamoto Y; Oka M
Anticancer Res; 2007; 27(5A):3323-30. PubMed ID: 17970077
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: a prospective, multicenter study.
Tanaka S; Mogushi K; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Yamamoto M; Kokudo N; Takayama T; Kawasaki S; Sakamoto M; Arii S
Hepatology; 2011 Oct; 54(4):1273-81. PubMed ID: 22006857
[TBL] [Abstract][Full Text] [Related]
17. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
18. Gene expression signature predicts recurrence in lung adenocarcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
[TBL] [Abstract][Full Text] [Related]
19. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
[TBL] [Abstract][Full Text] [Related]
20. Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.
Yano M; Hamatani K; Eguchi H; Hirai Y; MacPhee DG; Sugino K; Dohi K; Itamoto T; Asahara T
Eur J Cancer; 2007 Apr; 43(6):1092-100. PubMed ID: 17350822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
